Shining a Light on Selenium: a Meta-analysis of Supplementation in Multiple Sclerosis
Authors:
- Mehrab RahmaniMRMehrab Rahmani
- Sina PakkhesalSPSina Pakkhesal
- Saman BaharomidSBSaman Baharomid
- Hanie KarimiHKHanie Karimi
- Reza Mosaddeghi-HerisRMReza Mosaddeghi-Heris
- Mahnaz TalebiMTMahnaz Talebi
- Negar AghaeiNANegar Aghaei
- Alireza Rahimi-MamaghaniARAlireza Rahimi-Mamaghani
- Sarvin SanaieSSSarvin Sanaie
- Amirreza NaseriANAmirreza Naseri
- 29 December 2023
- journal article
- review article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (10) , 4375-4386
Abstract
Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system. Selenium is a trace element with significant antioxidant activity. This study aimed to seek evidence concerning selenium supplementation in MS. A systematic search was performed on PubMed, Web of Science, Scopus, and Embase databases to identify the studies assessing the consumption rate, efficacy, and safety of selenium and selenium-containing supplementations in MS patients. The meta-analysis was performed using the Comprehensive Meta-Analysis and the risk of bias was evaluated using the Joanna Briggs Institute’s critical appraisal tools. A total of 9 studies were included, which consisted of six studies regarding the rate of selenium supplement consumption in MS patients, with a total sample size of 2381 patients. Based on the quantitative synthesis, 14.3% (95% CI, 12.8–16.0%; I2, 3.58%) of MS patients had current selenium supplements usage, and 11.3% (95% CI, 7.6–16.6%; I2, 81.40%) of patients had used selenium supplements previously. Although there is no evidence regarding supplementation with selenium alone, three RCT studies reported the safety of selenium-containing supplementation use in MS with improved inflammation and oxidative stress conditions. The findings of this study show that over 10% of patients with MS used selenium supplements, with no clinical significance supporting the benefits. There is a lack of evidence regarding the safety and efficacy of selenium supplements in MS patients. Due to the limited number of included studies and the lack of comprehensive and specific studies regarding selenium supplements in MS, the results must be interpreted with caution, and future clinical trials are required.Keywords
This publication has 67 references indexed in Scilit:
- The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2012
- Effect of diphenyl diselenide on the development of experimental autoimmune encephalomyelitisNeurochemistry International, 2011
- Complementary and alternative medicines and dietary interventions in multiple sclerosis: What is being used in South Australia and why?Complementary Therapies in Medicine, 2009
- A review of complementary and alternative medicine (CAM) by people with multiple sclerosisOccupational Therapy International, 2009
- Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM UseEvidence-Based Complementary and Alternative Medicine, 2008
- The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosisComplementary Therapies in Medicine, 2005
- How frequently do patients with multiple sclerosis use complementary and alternative medicine?Complementary Therapies in Medicine, 2005
- Use of Alternative Treatments by People with Multiple SclerosisNeurorehabilitation and Neural Repair, 1999
- High dose antioxidant supplementation to MS patientsBiological Trace Element Research, 1990
- SELENIUM, VITAMIN E AND COPPER IN MULTIPLE SCLEROSISActa Neurologica Scandinavica, 1976